INKT MiNK Therapeutics, Inc. Net earnings per share growth this year

INKT (MiNK Therapeutics, Inc.) - company brandmark

MiNK Therapeutics, Inc. (INKT) focuses on developing universal methods for combating tumors via iNKT cells. The year-over-year EPS percentage deviation, based on data from the GURU.Markets chart, demonstrates the current vector, where the value 21.40 records this indicator. A lack of sales leads to capital burn on clinical trials, while supply reliability is ensured by certified cold-chain transport.

MiNK Therapeutics (INKT): Net earnings per share growth this year from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company MiNK Therapeutics, Inc (INKT)

- current quotes and average value forecast:
Summary company analysis:INKT (MiNK Therapeutics, Inc.)
Brand item of MiNK

This indicator captures the annual earnings per share (EPS) trend, reflecting the efficiency of the business's capitalization. For MiNK Therapeutics, Inc. (INKT), which invests in allogeneic iNKT therapies, this metric demonstrates the impact of extensive R&D expenditures on net income. By analyzing the 12-month EPS growth rate, investors can assess the speed of the transition from development to monetization. A positive trend confirms the financial stability of the innovator, serving as a key marker of the issuer's fundamental value.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|Werewolf - Earnings growth in current year|Earnings per share growth rate in current year Immix Biopharma|ALX Oncology (ALXO) - Earnings per share growth in current year|cuebiopharma.com (CUE) - Earnings growth in current year|PDSB (PDS Biotechnology Corp) - Earnings growth in current year|Earnings growth in current year sonnetbio.com|Earnings per share growth in current year MAIA Biotechnology, Inc. (MAIA)|LIMN: Earnings per share trend in current year|LAVA Therapeutics - Net earnings per share growth this year|nextcure.com (NXTC) - Earnings per share growth rate in current year|LPTX - Earnings per share growth in current year|Expected net earnings per share growth this year Intensity Therapeutics, Inc. INTS|SNSE: Earnings growth in current year|Synthetic Biologics - Earnings per share increase in current year|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year